What Researchers Did
Researchers reported on a 15-year-old male with chronic myelogenous leukaemia and BK virus-associated hemorrhagic cystitis who received 30 hyperbaric oxygen therapy (HBOT) treatments in the United States.
What They Found
After receiving 30 HBOT treatments, the 15-year-old patient showed significant improvement. Specifically, the patient experienced cessation of hemorrhagic cystitis, suggesting the therapy's effectiveness.
Canadian Relevance
This study has no direct Canadian connection as it reports on a case from the United States.
Study Limitations
A significant limitation of this study is that it is a single case report, which limits the generalizability of its findings.